Wall Street lifted price targets on three energy names this week. Targa Resources, Devon Energy, and Newmont all saw consensus targets nudge higher.
Targa's average target rose to $283.50 from $282.25. The midstream giant carries a market cap of $54.7 billion. 21 analysts hold buy ratings. Short interest sits at just 2.1% of free float — bears are staying away.
Devon's target edged up to $61.24. 20 analysts recommend buying. The oil producer has seen its target move steadily higher as crude markets stabilize.
Newmont's target climbed to $143.05. 18 analysts rate it a buy. The gold miner benefits from sustained bullion strength above $3,000 per ounce.
The medical device space told a different story. Stryker saw its consensus target trimmed to $389.24 from $389.43. A wave of recommendation removals swept through the sector. Boston Scientific, Edwards Lifesciences, , and all had analyst coverage adjusted.
BSX saw multiple simultaneous changes. Its consensus buy count fell to 27 from 29. Medtech faces margin pressure and tariff concerns in 2026.
The pattern is clear: energy and materials attract bulls. Healthcare hardware faces a tougher crowd.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
